These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 13781857

  • 1. The use of stelazine and parnate in chronic, withdrawn patients.
    VOGT AH.
    Am J Psychiatry; 1961 Sep; 118():256-7. PubMed ID: 13781857
    [No Abstract] [Full Text] [Related]

  • 2. Trifluoperazine and Tranylcypromine in chronic refractory schizophrenics.
    KRUSE W.
    Am J Psychiatry; 1960 Dec; 117():548-9. PubMed ID: 13754637
    [No Abstract] [Full Text] [Related]

  • 3. The unique therapeutic properties of tranylcypromine and trifluoperazine (parstelin).
    SCHIELE BC.
    Am J Psychiatry; 1960 Sep; 117():245-6. PubMed ID: 13747600
    [No Abstract] [Full Text] [Related]

  • 4. The relative merits of tranylcypromine alone and tranylcypromine in combination with trifluoperazine in the treatment of patients with severe agitated depressions.
    LESSE S.
    Am J Psychiatry; 1962 Apr; 118():934-5. PubMed ID: 14464348
    [No Abstract] [Full Text] [Related]

  • 5. Combined use of tranylcypromine and trifluoperazine in ambulatory treatment of patients with agitated depressions: Preliminary evaluation.
    LESSE S.
    N Y State J Med; 1961 Jun 01; 61():1898-903. PubMed ID: 13761180
    [No Abstract] [Full Text] [Related]

  • 6. The effect of tranylcypromine-trifluoperazine in the treatment of depressive states.
    BRAM G.
    Can Psychiatr Assoc J; 1962 Jun 01; 7(Suppl)():84-6. PubMed ID: 13872435
    [No Abstract] [Full Text] [Related]

  • 7. The use of tranylcypromine and trifluoperazine in the management of coexisting depression and anxiety.
    GODDARD ES.
    Can Psychiatr Assoc J; 1962 Jun 01; 7(Suppl)():87-90. PubMed ID: 13899397
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The prediction of response to tranylcypromine plus trifluoperazine by the MMPI.
    SULZER ES, SCHIELE BC.
    Am J Psychiatry; 1962 Jul 01; 119():69-70. PubMed ID: 13918361
    [No Abstract] [Full Text] [Related]

  • 10. Neuropharmacology of tranylcypromine and trifluoperazine.
    TEDESCHI RE, TEDESCHI DH, FELLOWS EJ.
    Can Psychiatr Assoc J; 1962 Jul 01; 7(Suppl)():55-9. PubMed ID: 13920073
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical trial of "stelazine" on apathetic chronic schizophrenics.
    WECKOWICZ TE, WARD TF.
    J Ment Sci; 1960 Jul 01; 106():1008-15. PubMed ID: 13783682
    [No Abstract] [Full Text] [Related]

  • 15. [Changes in the Rorschach psychodiagnostic test during treatments of chronic schizophrenics with Stelazine].
    MELGAR MC.
    Dia Med; 1962 Feb 05; 34():130-3. PubMed ID: 14472352
    [No Abstract] [Full Text] [Related]

  • 16. A comparison of results in schizophrenics treated with (1) insulin, (2) trifluoperazine ("Stelazine").
    MCNEILL DL, MADGWICK JR.
    J Ment Sci; 1961 Mar 05; 107():297-9. PubMed ID: 13774153
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A double-blind trial to investigate the effects of Thorazine (Largactil, chlorpromazine), Compazine (Stemetil, prochlorperazine) and Stelazine (trifluoperazine) in paranoid schizophrenia.
    WILSON IC, McKAY J, SANDIFER MG.
    J Ment Sci; 1961 Jan 05; 107():90-9. PubMed ID: 13785665
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.